Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037229 · ClinicalTrials.gov registry record
Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT03037229: Completed study, sponsored by Mayo Clinic.
NCT03037229 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03037229 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Is the Smartphone ECG (electrocardiogram) an acceptable replacement for a standard ECG in the identification of STEMI (ST Elevation Myocardial Infarction).
Interventions
- DEVICE Smartphone ECG
- DEVICE Standard 12-lead ECG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-12-29 |
| Est. Completion | 2018-12-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03037229
The ClinicalTrials.gov registry entry for NCT03037229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smartphone ECG is the first listed.
NCT03037229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03037229 about?
NCT03037229 is a clinical study titled "Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction". Is the Smartphone ECG (electrocardiogram) an acceptable replacement for a standard ECG in the identification of STEMI (ST Elevation Myocardial Infarction).
What is the current status of trial NCT03037229?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-12-29. Estimated completion is 2018-12-06.
What interventions are being tested in trial NCT03037229?
The interventions under investigation include: Smartphone ECG (DEVICE), Standard 12-lead ECG (DEVICE).
Who is sponsoring clinical trial NCT03037229?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.